AMGN — AMGEN INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 318154 ·
Last close
$358.33
Market Cap
$193.39B
52W High
$362.27
52W Low
$318.12
ADV30
2,948,077
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 8,618,000,000 | 5,874,000,000 | 2,666,000,000 | 1,819,000,000 | 92,504,000,000 | 12,038,000,000 | 83,314,000,000 |
| Dec 2025 | 9,866,000,000 | 6,890,000,000 | 2,720,000,000 | 1,333,000,000 | 90,586,000,000 | 9,129,000,000 | 81,928,000,000 |
| Sep 2025 | 9,557,000,000 | 6,475,000,000 | 2,526,000,000 | 3,216,000,000 | 90,141,000,000 | 9,445,000,000 | 80,522,000,000 |
| Jun 2025 | 9,179,000,000 | 6,168,000,000 | 2,656,000,000 | 1,432,000,000 | 87,897,000,000 | 8,028,000,000 | 80,469,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$10,756,000,000
Investing CF
$-2,212,000,000
Financing CF
$-5,316,000,000
CapEx
$-2,159,000,000
Dividends Paid
$-5,203,000,000
Buybacks
—
EPS Diluted TTM
$14.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-24,650,000,000
Inventory
$6,186,000,000
Receivables
$9,138,000,000
ST Investments
—
EBIT TTM
$11,776,000,000
Pretax Income TTM
$9,087,000,000
Interest Exp TTM
$2,689,000,000
Analysts
30
Yahoo Snapshot (yfinance, live)
Total Revenue
$37,219,999,744
EBITDA
$16,917,999,616
Free Cash Flow
$7,436,624,896
Enterprise Value
$238,678,671,360
Total Cash
$12,037,999,616
Total Debt
$57,322,999,808
Shares Out
539,708,274
Trailing EPS
$14.37
Book Value
$17.03
ROE
101.3%
ROA
8.3%
Div Yield
2.81%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,751,000,000 | 9,080,000,000 | 7,711,000,000 | 90,586,000,000 | 81,928,000,000 | — | 9,958,000,000 |
| Dec 2024 | 33,424,000,000 | 7,258,000,000 | 4,090,000,000 | 91,839,000,000 | 85,962,000,000 | — | 11,490,000,000 |
| Dec 2023 | 28,190,000,000 | 7,897,000,000 | 6,717,000,000 | 97,154,000,000 | 90,922,000,000 | — | 8,471,000,000 |
| Dec 2022 | 26,323,000,000 | 9,566,000,000 | 6,552,000,000 | 65,121,000,000 | 61,460,000,000 | — | 9,721,000,000 |
TTM Snapshot
Revenues TTM
$28,764,000,000
NetIncome TTM
$8,587,000,000
OpCashFlow TTM
$0
Assets (Latest)
$91,839,000,000
Forward EPS
$23.48
Max Pain — expiry 2026-07-02
max pain strike: $345.00 · spot: $359.26 · call oi: 2,933 · put oi: 2,176
Expected Move to 2026-07-02:
±$7.04
(1.96%) —
implied range
$352.22 –
$366.31
· ATM straddle on $360.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GILD | GILEAD SCIENCES, INC. | $158.77B | $127.88 | — |
| ARGX | ARGENX SE | $55.17B | $887.18 | — |
| RVMD | Revolution Medicines, Inc. | $38.71B | $182.08 | — |
| BIIB | BIOGEN INC. | $31.89B | $216.03 | — |
| MRNA | Moderna, Inc. | $26.69B | $67.27 | — |
News headlines (Yahoo Finance, 1h cache)
UBS, BofA, Jefferies Start Quantinuum With Buy Ratings On 'Full-Stack' Platform
2026-06-29 15:04 · Yahoo
Alphabet Is Joining the Dow Jones Industrial Average. 3 Surprising Reasons Why SpaceX Could Be Next.
2026-06-27 14:20 · Yahoo
Amgen's Tavneos Faces EU Revocation After CHMP Review
2026-06-26 12:21 · Yahoo
Piper Sandler and Morgan Stanley Highlight Amgen (AMGN) on Pipeline Strength and Obesity Drug Potential
2026-06-26 11:11 · Yahoo
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off
2026-06-25 09:13 · Yahoo
Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know
2026-06-24 21:50 · Yahoo
Amgen Inc. (AMGN) Price Target Raised to $303 After Q1 Model Update
2026-06-24 13:27 · Yahoo
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
2026-06-23 23:53 · Yahoo
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.
2026-06-23 15:50 · Yahoo
Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?
2026-06-23 13:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.